Related Experiment Video
Updated: May 6, 2026
04:40
Author Spotlight: Advancing Cancer Associated Thrombosis Research in Rodent Models
Published on: January 5, 2024
3.2K
Primary venous thromboembolism prophylaxis in patients with solid tumors: a meta-analysis
Minh Phan1, Sonia John, Ana I Casanegra
1Internal Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.
Journal of Thrombosis and Thrombolysis
|November 16, 2013
Summary
Venous thromboembolism (VTE) prevention is crucial for outpatient chemotherapy patients. Prophylaxis significantly reduces VTE events, particularly with heparin, but increases bleeding risk. Personalized strategies are needed.
Area of Science:
- Oncology
- Hematology
- Clinical Pharmacology
Background:
- Venous thromboembolism (VTE) is a significant cause of mortality in cancer patients receiving outpatient chemotherapy.
- Preventive measures for VTE in this population are not widely implemented.
- Evidence on the effectiveness and safety of outpatient VTE prophylaxis is limited.
Purpose of the Study:
- To conduct a meta-analysis evaluating the effectiveness of VTE preventive measures in outpatient chemotherapy patients.
- To assess the safety profile of VTE prophylaxis, focusing on major bleeding events.
- To identify specific cancer types or prophylaxis regimens with stronger VTE prevention benefits.
Main Methods:
- Systematic literature search of electronic databases up to December 2012, adhering to PRISMA guidelines.
- Meta-analysis of 11 randomized controlled trials involving 7,805 patients.
- Pooled odds ratios (OR) using Mantel-Haenszel fixed-effects model for VTE occurrence and major bleeding.
Main Results:
- Prophylaxis significantly reduced the odds of VTE (OR 0.56; 95% CI 0.45-0.71).
- Heparin-based prophylaxis showed a stronger effect (OR 0.53; 95% CI 0.41-0.70), reducing VTE by 47%.
- Significant VTE reduction was observed in lung and pancreatic cancer patients. However, major bleeding events increased by 60% (OR 1.65; 95% CI 1.12-2.44).
Conclusions:
- Thromboprophylaxis is effective in reducing VTE episodes in outpatient chemotherapy patients.
- Heparin-based prophylaxis offers substantial VTE risk reduction but is associated with a notable increase in bleeding events.
- Enhanced risk stratification tools are necessary for personalized VTE prevention strategies in cancer patients.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:30Venous Thrombosis IV: Nursing Management
418
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
418
01:30Venous Thrombosis I: Introduction
831
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
831
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
470
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
470
01:27Pulmonary Embolism III: Nursing Management
756
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
756
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
760
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
760